Skip to main content
SNOA logo
SNOA
(NASDAQ)
Sonoma Pharmaceuticals, Inc.
$2.37-- (--)
Loading... - Market loading

Sonoma Pharmaceuticals (SNOA) Balance Sheet

Assets, liabilities, and shareholders' equity with annual and quarterly data.

Sonoma Pharmaceuticals Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Sonoma Pharmaceuticals, Inc. (SNOA) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2022FY 2021FY 2021FY 2020FY 2019FY 2018FY 2017
Period EndingMar 2025Mar 2024Mar 2023Jun 2022Mar 2022Jun 2021Mar 2021Jun 2020Jun 2019Mar 2018Mar 2017
Current Assets
Cash and Cash Equivalents5.373.133.827.407.404.224.223.693.6910.0717.46
Cash & Short-Term Investments5.373.133.827.407.404.224.223.693.6910.0717.46
Accounts Receivable3.763.162.812.412.412.813.023.973.481.542.11
Inventory2.922.722.862.662.662.532.532.193.412.872.22
Other Current Assets0.603.544.313.960.623.433.222.531.921.790.85
Total Current Assets12.6512.5513.8016.4316.4312.9812.9812.3812.5016.2522.64
Non-Current Assets
Property, Plant & Equipment (Net)0.310.650.910.880.881.131.131.330.731.141.24
Other Non-Current Assets0.150.400.580.710.080.880.880.851.231.821.58
Total Non-Current Assets1.052.192.432.422.422.000.002.181.952.952.82
Total Assets13.6914.7416.2318.8518.8514.9914.9914.5614.4519.2125.46
Current Liabilities
Accounts Payable0.950.610.841.641.641.771.772.071.261.271.26
Short-Term Debt0.280.520.431.060.810.840.000.620.460.380.20
Current Portion of Long-Term Debt0.000.000.000.000.120.000.000.000.000.000.00
Accrued Liabilities1.741.421.460.001.060.000.790.000.000.000.00
Deferred Revenue0.640.480.161.281.280.320.320.270.100.210.52
Other Current Liabilities2.220.690.57-2.000.78-2.320.371.771.771.410.68
Total Current Liabilities4.103.723.725.825.824.084.084.733.593.263.29
Non-Current Liabilities
Long-Term Debt0.030.090.160.310.311.841.310.240.010.180.21
Deferred Tax Liabilities0.000.000.000.000.000.000.000.000.00-0.14-0.17
Other Non-Current Liabilities5.144.714.243.843.843.483.483.730.000.140.00
Total Non-Current Liabilities5.194.884.544.334.335.550.004.210.370.620.74
Total Liabilities9.288.608.2510.1510.159.629.628.943.963.884.03
Stockholders' Equity
Common Stock0.000.000.010.000.000.000.000.000.000.000.00
Retained Earnings-197.81-194.35-189.51-184.36-184.36-179.28-179.28-175.33-169.24-157.44-143.10
Accumulated Other Comprehensive Income-4.38-2.72-3.42-4.31-4.31-4.58-4.58-5.61-4.35-3.98-4.18
Additional Paid-in Capital206.59203.21200.90197.37197.37189.220.00186.56184.07176.74168.71
Shares Outstanding1.630.780.250.000.160.000.000.000.000.000.00
Total Stockholders' Equity4.416.147.988.708.705.365.365.6210.4915.3321.43
Total Liabilities & Equity13.6914.7416.2318.8518.8514.990.0014.5614.4519.2125.46

Frequently Asked Questions About Sonoma Pharmaceuticals Balance Sheet

What is a balance sheet?

A balance sheet shows a company's financial position at a specific point in time. It lists total assets (what the company owns), total liabilities (what it owes), and stockholders' equity (the difference). The fundamental equation: Assets = Liabilities + Equity.

What is stockholders' equity?

Stockholders' equity represents the net value belonging to shareholders — total assets minus total liabilities. It includes retained earnings, common stock, and additional paid-in capital. Growing equity over time typically indicates a healthy, profitable business.

What is working capital?

Working capital is current assets minus current liabilities. It measures a company's ability to pay short-term obligations with short-term assets. Positive working capital indicates the company can cover its near-term debts; negative may signal liquidity risk.

What is SNOA's debt level?

Review Sonoma Pharmaceuticals's total long-term debt and short-term borrowings in the balance sheet table above. Compare debt to equity and total assets to assess leverage and financial risk.

What is book value per share?

Book value per share is total stockholders' equity divided by shares outstanding. It represents the accounting value per share if the company were liquidated. Comparing market price to book value gives the price-to-book (P/B) ratio — a key valuation metric.

These financial metrics are calculated using balance sheet data. Learn how each metric works and screen stocks by them.